Growth Metrics

GeneDx Holdings (WGS) Gross Profit (2020 - 2026)

GeneDx Holdings has reported Gross Profit over the past 7 years, most recently at $68.2 million for Q1 2026.

  • Quarterly Gross Profit rose 16.65% to $68.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $307.9 million through Mar 2026, up 42.91% year-over-year, with the annual reading at $298.2 million for FY2025, 53.38% up from the prior year.
  • Gross Profit was $68.2 million for Q1 2026 at GeneDx Holdings, down from $84.3 million in the prior quarter.
  • Over five years, Gross Profit peaked at $84.5 million in Q3 2025 and troughed at -$29.6 million in Q2 2022.
  • The 5-year median for Gross Profit is $37.4 million (2024), against an average of $36.7 million.
  • Year-over-year, Gross Profit tumbled 2442.78% in 2022 and then soared 288.37% in 2023.
  • A 5-year view of Gross Profit shows it stood at -$16.3 million in 2022, then soared by 288.37% to $30.8 million in 2023, then skyrocketed by 115.27% to $66.2 million in 2024, then grew by 27.28% to $84.3 million in 2025, then decreased by 19.05% to $68.2 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Gross Profit are $68.2 million (Q1 2026), $84.3 million (Q4 2025), and $84.5 million (Q3 2025).